SK155694A3 - Glucagon-like peptide, insulinotropin derivatives, method of their preparation, pharmaceutical agent containing and using these matters - Google Patents
Glucagon-like peptide, insulinotropin derivatives, method of their preparation, pharmaceutical agent containing and using these matters Download PDFInfo
- Publication number
- SK155694A3 SK155694A3 SK1556-94A SK155694A SK155694A3 SK 155694 A3 SK155694 A3 SK 155694A3 SK 155694 A SK155694 A SK 155694A SK 155694 A3 SK155694 A3 SK 155694A3
- Authority
- SK
- Slovakia
- Prior art keywords
- glu
- gly
- ala
- ser
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89907392A | 1992-06-15 | 1992-06-15 | |
PCT/US1993/003388 WO1993025579A1 (en) | 1992-06-15 | 1993-04-14 | Glucagon-like peptide and insulinotropin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SK155694A3 true SK155694A3 (en) | 1995-05-10 |
Family
ID=25410453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1556-94A SK155694A3 (en) | 1992-06-15 | 1993-04-14 | Glucagon-like peptide, insulinotropin derivatives, method of their preparation, pharmaceutical agent containing and using these matters |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP0646128A1 (no) |
JP (1) | JP2575298B2 (no) |
KR (1) | KR0154880B1 (no) |
CN (1) | CN1057098C (no) |
AU (1) | AU671117B2 (no) |
BR (1) | BR9306551A (no) |
CA (1) | CA2138161C (no) |
CZ (1) | CZ315594A3 (no) |
FI (1) | FI932722A (no) |
HR (1) | HRP930993A2 (no) |
HU (2) | HUT64367A (no) |
IL (1) | IL105928A0 (no) |
MX (1) | MX9303554A (no) |
NO (1) | NO944853L (no) |
PL (1) | PL176007B1 (no) |
RU (1) | RU2128663C1 (no) |
SK (1) | SK155694A3 (no) |
WO (1) | WO1993025579A1 (no) |
YU (1) | YU41493A (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
US5705483A (en) | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
GB9409496D0 (en) * | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
US5574008A (en) * | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide |
US5512549A (en) * | 1994-10-18 | 1996-04-30 | Eli Lilly And Company | Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
AU4415796A (en) * | 1994-12-07 | 1996-06-26 | Bionebraska, Inc. | Production of c-terminal amidated peptides from recombinant protein constructs |
US5990077A (en) * | 1995-04-14 | 1999-11-23 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
US5834428A (en) | 1995-04-14 | 1998-11-10 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
US6184201B1 (en) | 1995-04-14 | 2001-02-06 | Nps Allelix Corp. | Intestinotrophic glucagon-like peptide-2 analogs |
US5747453A (en) * | 1995-06-06 | 1998-05-05 | Alza Corporation | Method for increasing the electrotransport flux of polypeptides |
US6333189B1 (en) | 1996-06-06 | 2001-12-25 | Alza Corporation | Method of making an electrotransport device |
US6006753A (en) * | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
UA65549C2 (uk) | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
DE122007000044I2 (de) | 1997-01-07 | 2011-05-05 | Amylin Pharmaceuticals Inc | Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme |
US5981488A (en) * | 1997-03-31 | 1999-11-09 | Eli Lillly And Company | Glucagon-like peptide-1 analogs |
US7157555B1 (en) | 1997-08-08 | 2007-01-02 | Amylin Pharmaceuticals, Inc. | Exendin agonist compounds |
ATE381939T1 (de) | 1997-11-14 | 2008-01-15 | Amylin Pharmaceuticals Inc | Neuartige exendin agonisten |
US7223725B1 (en) | 1997-11-14 | 2007-05-29 | Amylin Pharmaceuticals, Inc. | Exendin agonist compounds |
US6380357B2 (en) | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
FR2777283B1 (fr) * | 1998-04-10 | 2000-11-24 | Adir | Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP1105460B1 (en) | 1998-08-10 | 2009-10-07 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
EP1992641A3 (en) * | 1998-12-07 | 2009-07-29 | Ipsen Pharma | GLP-1 analogues |
US6514500B1 (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
SI1180121T1 (en) | 1999-05-17 | 2004-04-30 | Conjuchem, Inc. | Long lasting insulinotropic peptides |
ATE416784T1 (de) | 2000-12-01 | 2008-12-15 | Takeda Pharmaceutical | Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz |
WO2002048192A2 (en) | 2000-12-13 | 2002-06-20 | Eli Lilly And Company | Amidated glucagon-like peptide-1 |
PT1463751E (pt) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Proteínas de fusão de albumina |
MXPA04008068A (es) | 2002-02-20 | 2004-11-26 | Lilly Co Eli | Metodo para administrar moleculas de glp-1. |
US20060286129A1 (en) | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
JP2007537149A (ja) | 2004-01-08 | 2007-12-20 | セラテクノロジーズ インコーポレイテッド | 長時間作用性のグルカゴン様ペプチド−1類似体 |
US8039432B2 (en) | 2005-11-09 | 2011-10-18 | Conjuchem, Llc | Method of treatment of diabetes and/or obesity with reduced nausea side effect |
EP2307038A4 (en) | 2008-06-27 | 2013-03-27 | Univ Duke | THERAPEUTIC AGENTS COMPRISING ELASTINE-LIKE PEPTIDES |
WO2012006598A2 (en) | 2010-07-09 | 2012-01-12 | Dana-Farber Cancer Institute, Inc. | Stabilized insulinotropic peptides and methods of use |
JP6224586B2 (ja) | 2012-07-10 | 2017-11-01 | 武田薬品工業株式会社 | 注射用製剤 |
US10639354B2 (en) | 2015-05-22 | 2020-05-05 | The Bot Of The Leland Stanford Junior University | Treatment of hyperinsulinemic hypoglycemia with exendin (9-39) |
US20190290772A1 (en) * | 2016-06-02 | 2019-09-26 | Indiana University Research And Technology Corporation | Glucagon-like peptide-1-t3 conjugates |
US11020484B2 (en) | 2016-11-21 | 2021-06-01 | Eiger Biopharmaceuticals, Inc. | Buffered formulations of exendin (9-39) |
PE20211202A1 (es) | 2017-08-24 | 2021-07-05 | Novo Nordisk As | Composiciones de glp-1 y sus usos |
WO2021144476A1 (en) | 2020-02-18 | 2021-07-22 | Novo Nordisk A/S | Pharmaceutical formulations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68929217T2 (de) * | 1989-03-20 | 2000-11-30 | Gen Hospital Corp | Insulinotropes hormon |
EP0512042B1 (en) * | 1990-01-24 | 1998-04-08 | BUCKLEY, Douglas I. | Glp-1 analogs useful for diabetes treatment |
ES2087323T3 (es) * | 1991-02-19 | 1996-07-16 | Takeda Chemical Industries Ltd | Metodo para producir peptidos exentos de cisteina. |
DK36392D0 (da) * | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Anvendelse af kemisk forbindelse |
DK36492D0 (da) * | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Praeparat |
DK39892D0 (da) * | 1992-03-25 | 1992-03-25 | Bernard Thorens | Peptid |
-
1993
- 1993-04-14 KR KR1019940704555A patent/KR0154880B1/ko not_active IP Right Cessation
- 1993-04-14 CZ CZ943155A patent/CZ315594A3/cs unknown
- 1993-04-14 PL PL93306766A patent/PL176007B1/pl unknown
- 1993-04-14 EP EP93909505A patent/EP0646128A1/en not_active Ceased
- 1993-04-14 BR BR9306551A patent/BR9306551A/pt not_active Application Discontinuation
- 1993-04-14 WO PCT/US1993/003388 patent/WO1993025579A1/en not_active Application Discontinuation
- 1993-04-14 CA CA002138161A patent/CA2138161C/en not_active Expired - Lifetime
- 1993-04-14 SK SK1556-94A patent/SK155694A3/sk unknown
- 1993-04-14 AU AU40275/93A patent/AU671117B2/en not_active Expired
- 1993-04-14 JP JP6501448A patent/JP2575298B2/ja not_active Expired - Lifetime
- 1993-04-14 RU RU94046251A patent/RU2128663C1/ru active
- 1993-04-14 EP EP99110184A patent/EP0969016A2/en not_active Withdrawn
- 1993-06-07 IL IL105928A patent/IL105928A0/xx not_active IP Right Cessation
- 1993-06-14 HU HU9301739A patent/HUT64367A/hu unknown
- 1993-06-14 YU YU41493A patent/YU41493A/sh unknown
- 1993-06-14 CN CN93108718A patent/CN1057098C/zh not_active Expired - Fee Related
- 1993-06-14 FI FI932722A patent/FI932722A/fi unknown
- 1993-06-15 MX MX9303554A patent/MX9303554A/es active IP Right Grant
- 1993-06-24 HR HR07/899,073A patent/HRP930993A2/xx not_active Application Discontinuation
-
1994
- 1994-12-14 NO NO944853A patent/NO944853L/no not_active Application Discontinuation
-
1995
- 1995-06-28 HU HU95P/P00479P patent/HU211498A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
CN1057098C (zh) | 2000-10-04 |
MX9303554A (es) | 1994-06-30 |
EP0969016A2 (en) | 2000-01-05 |
KR0154880B1 (ko) | 1998-10-15 |
PL176007B1 (pl) | 1999-03-31 |
AU671117B2 (en) | 1996-08-15 |
HRP930993A2 (en) | 1996-12-31 |
BR9306551A (pt) | 1998-09-15 |
IL105928A0 (en) | 1993-10-20 |
WO1993025579A1 (en) | 1993-12-23 |
FI932722A0 (fi) | 1993-06-14 |
CA2138161A1 (en) | 1993-12-23 |
FI932722A (fi) | 1993-12-16 |
EP0646128A1 (en) | 1995-04-05 |
AU4027593A (en) | 1994-01-04 |
JPH07504679A (ja) | 1995-05-25 |
HUT64367A (en) | 1993-12-28 |
CN1085913A (zh) | 1994-04-27 |
KR950701937A (ko) | 1995-05-17 |
HU211498A9 (en) | 1995-11-28 |
RU94046251A (ru) | 1996-10-27 |
CA2138161C (en) | 2003-10-21 |
NO944853D0 (no) | 1994-12-14 |
HU9301739D0 (en) | 1993-09-28 |
CZ315594A3 (en) | 1995-07-12 |
NO944853L (no) | 1994-12-14 |
JP2575298B2 (ja) | 1997-01-22 |
RU2128663C1 (ru) | 1999-04-10 |
YU41493A (sh) | 1996-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK155694A3 (en) | Glucagon-like peptide, insulinotropin derivatives, method of their preparation, pharmaceutical agent containing and using these matters | |
KR102444783B1 (ko) | 인크레틴 유사체 및 그의 용도 | |
AU2017216533B2 (en) | Improved peptide pharmaceuticals | |
JP3759748B2 (ja) | 成長ホルモン放出性を有する化合物 | |
KR101205272B1 (ko) | 아실화된 glp-1 화합물 | |
US6921748B1 (en) | Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes | |
KR102255479B1 (ko) | 인슐린 저항성에 대한 개선된 펩티드 제약 | |
EP2036923A1 (en) | Improved derivates of amylin | |
WO2014049610A2 (en) | Peptides as gip, glp-1 and glucagon receptors triple-agonist | |
JP2013209399A (ja) | エキセンディン−4およびエキセンディン−3の類似体 | |
KR20110043686A (ko) | 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체 | |
CA2335341A1 (en) | Peptide analogues of pacap | |
EP2413955A2 (en) | N-terminus conformationally constrained glp-1 receptor agonist compounds | |
JPH11152299A (ja) | 新規アミリン作動薬ペプチドおよびその使用 | |
US8383581B2 (en) | Short-chain peptides as parathyroid hormone (PTH) receptor agonist | |
JP2011525895A (ja) | アミリン及びサケカルシトニンの誘導体化ハイブリッドペプチド | |
JPH0769919A (ja) | Vip,その類縁体またはそのフラグメントを含む医薬組成物 | |
CN112608378A (zh) | 一类glp-1/胆囊收缩素-1受体双重激动剂及其应用 | |
CN101223189A (zh) | 作为glp-i激动剂的新颖化合物 | |
TWI428139B (zh) | A novel glucagon-like peptide analogue, a composition and use thereof |